- Companies
- Beamtree
Beamtree Valuation Multiples
Beamtree is valued at $21M as of September 2026, a 1.0x revenue multiple. In the last 12 months, Beamtree revenue was $21M and Beamtree EBITDA was $632K.
Beamtree Overview
About Beamtree
Beamtree Holdings Ltd is an Artificial intelligence (AI) health technology company. It offers software solutions like Picq, RippleDown, Risq, Ainsoff, Q Coding platform, and others across four product segments that combine into a modular software suite to assist healthcare services in transforming the quality of their data, analyzing key performance insights, and improving actionable decision support. The company's key operating product segments are: Knowledge Networks, which generate maximum revenue, Diagnostics, Clinical Decision Support, and Coding and Data Quality Assurance. Geographically, it operates in Australia, its key revenue-generating market, Europe, and the Rest of the world.
Founded
2018
HQ
Employees
97
Website
Sectors
Financials (LTM)
EV
$22M
Valuation Multiples
Start free trialBeamtree Financials
Beamtree reported last 12-month revenue of $21M and EBITDA of $632K.
In the same LTM period, Beamtree generated $632K in EBITDA and had net loss of ($10M).
Revenue (LTM)
Beamtree P&L
In the most recent fiscal year, Beamtree reported revenue of $20M and EBITDA of ($501K).
Beamtree is unprofitable as of last fiscal year, with gross margin of 100%, EBITDA margin of (2%), and net margin of (22%).
Financial data powered by Morningstar, Inc.
Beamtree Stock Performance
Beamtree has current market cap of $21M, and enterprise value of $22M.
Market Cap Evolution
Beamtree's stock price is $0.07.
Beamtree share price decreased by 10.9% in the last 30 days, and by 53.6% in the last year.
Beamtree has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $22M | $21M | -0.3% | -10.9% | -27.1% | -53.6% | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBeamtree Valuation Multiples
Beamtree trades at 1.0x EV/Revenue multiple, and 34.6x EV/EBITDA.
EV / Revenue (LTM)
Beamtree Financial Valuation Multiples
As of September 26, 2026, Beamtree has market cap of $21M and EV of $22M.
Beamtree has a P/E ratio of (2.0x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Beamtree Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Beamtree Margins & Growth Rates
Beamtree grew revenue by 4% but EBITDA decreased by 186% in the last fiscal year.
In the most recent fiscal year, Beamtree reported gross margin of 100%, EBITDA margin of (2%), and net margin of (22%).
Beamtree Margins
Beamtree Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Beamtree Operational KPIs
Beamtree's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Beamtree's Rule of 40 is 5% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Beamtree's Rule of X is 6% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Beamtree Competitors
Beamtree competitors include Emimen, MRT, Terranet, MRSO, Firefly Neuroscience, Global Mofy AI, Vida Global, Pathkey.AI, Insig AI and Nowigence.
Most Beamtree public comparables operate across Health Data & Analytics, Vertical AI Applications, Artificial Intelligence, B2B SaaS, Horizontal SaaS, DeepTech and HealthTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $12M | $777K | 1.7x | 1.6x | 25.4x | - | |||
| $26M | $2M | 0.4x | 0.4x | 5.4x | - | |||
| - | ($4M) | - | - | (4.0x) | - | |||
| $7M | ($199K) | 1.2x | 1.2x | (41.4x) | - | |||
| $1M | ($20M) | 8.3x | - | (0.5x) | - | |||
| $56M | ($6M) | 0.4x | - | (3.1x) | - | |||
| $551K | ($2M) | 18.2x | - | (4.2x) | - | |||
| $20K | ($960K) | 1142.1x | - | (23.2x) | - | |||
This data is available for Pro users. Sign up to see all Beamtree competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Beamtree
Beamtree has acquired 3 companies to date.
Last acquisition by Beamtree was on August 30th 2021. Beamtree acquired Potential(x) for $14M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Beamtree
| Description | Potential(x) is an Australian health data company that collects, standardises and benchmarks clinical and financial outcomes data for hospitals. Its products let hospital groups compare cost, length of stay and clinical performance against peers, and it was built around the data assets of the Health Roundtable, which was a selling shareholder. At the time of its sale it was contributing revenue and operating EBITDA large enough to roughly double the revenue of its acquirer. | - | Pavilion Health is an Australian health data business whose software audits hospital clinical coding, checks documentation quality and reports casemix and risk information. Its tools are used by public and private hospital operators to improve the accuracy of the coded activity data that drives funding, benchmarking and clinical risk reporting. The company reported sales of A$4.4 million and operational EBITDA of A$1.66 million in FY2019 before being acquired by ASX-listed PKS Holdings in 2020. |
| HQ Country | |||
| HQ City | Sydney | Sydney | - |
| Deal Date | 30 Aug 2021 | 27 Aug 2021 | 19 Apr 2020 |
| Valuation | $14M | $1M | $6M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Beamtree acquisitions and their M&A valuation multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Beamtree
| When was Beamtree founded? | Beamtree was founded in 2018. |
| Where is Beamtree headquartered? | Beamtree is headquartered in Australia. |
| How many employees does Beamtree have? | As of today, Beamtree has over 97 employees. |
| Is Beamtree publicly listed? | Yes, Beamtree is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Beamtree? | Beamtree trades under BMT ticker. |
| When did Beamtree go public? | Beamtree went public in 2019. |
| Who are competitors of Beamtree? | Beamtree main competitors include Emimen, MRT, Terranet, MRSO, Firefly Neuroscience, Global Mofy AI, Vida Global, Pathkey.AI, Insig AI, Nowigence. |
| What is the current market cap of Beamtree? | Beamtree's current market cap is $21M. |
| What is the current revenue of Beamtree? | Beamtree's last 12 months revenue is $21M. |
| What is the current revenue growth of Beamtree? | Beamtree revenue growth (NTM/LTM) is 0%. |
| What is the current EV/Revenue multiple of Beamtree? | Current revenue multiple of Beamtree is 1.0x. |
| What is the current EBITDA of Beamtree? | Beamtree's last 12 months EBITDA is $632K. |
| What is Beamtree's EBITDA margin? | Beamtree's last 12 months EBITDA margin is 3%. |
| What is the current EV/EBITDA multiple of Beamtree? | Current EBITDA multiple of Beamtree is 34.6x. |
| What is the current FCF of Beamtree? | Beamtree's last 12 months FCF is ($2M). |
| What is Beamtree's FCF margin? | Beamtree's last 12 months FCF margin is (11%). |
| What is the current EV/FCF multiple of Beamtree? | Current FCF multiple of Beamtree is (9.9x). |
| How many companies Beamtree has acquired to date? | As of September 2026, Beamtree has acquired 3 companies. |
| What was the largest acquisition by Beamtree? | $14M acquisition of Potential(x) on 30th August 2021 was the largest M&A Beamtree has done to date. |
| What companies Beamtree acquired? | Beamtree acquired Potential(x), Pavilion Health, and Ainsoff. |
| In how many companies Beamtree has invested to date? | Beamtree hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Beamtree
Lists including Beamtree
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




